BioPharmGuy logo
Sponsored By:
Project Management Now
Purchase the BioPharmGuy data
Trianni
Syrrx is defunct.

Fate: Acquired by Takeda, Feb 2005, $270M


------------------
If you believe any of this information is incorrect, please let us know.